Green Preparation Process, Characterization and Antitumor Effects of Doxorubicin-BSA-Dextran Nanoparticles

被引:53
作者
Deng, Wei [1 ,2 ]
Li, Juan [1 ,2 ]
Yao, Ping [1 ,2 ]
He, Fen [3 ]
Huang, Chong [3 ]
机构
[1] Fudan Univ, Key Lab Mol Engn Polymer, Shanghai 200433, Peoples R China
[2] Fudan Univ, Dept Macromol Sci, Shanghai 200433, Peoples R China
[3] Natl Pharmaceut Engn Res Ctr, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
albumin; dextran; doxorubicin; drug delivery system; nanoparticles; BOVINE SERUM-ALBUMIN; TARGETED DRUG-DELIVERY; PROTEIN NANOPARTICLES; CREMOPHOR-FREE; CARDIOTOXICITY; NANOSPHERES; FORMULATION; PACLITAXEL; COPOLYMERS; MICELLES;
D O I
10.1002/mabi.201000125
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this report, we developed a simple and green process of simultaneous formation of doxorubicin-BSA-dextran nanoparticles in aqueous solution and high-effective encapsulation of doxorubicin. In the presence of BSA-dextran conjugates, which were produced by Maillard reaction, a binding of doxorubicin with BSA can suppress the self-aggregation of unprotonated doxorubicin. After a heat treatment, the gelation of BSA results in a formation of the nanoparticles and the doxorubicin was fixed inside the nanoparticles. The dextran shell makes the nanoparticles dispersible in solution. The nanoparticles have a spherical morphology and a hydrodynamic radius of about 90 nm. Importantly, the nanoparticles can significantly prolong the life of murine ascites hepatoma H22 tumor-bearing mice.
引用
收藏
页码:1224 / 1234
页数:11
相关论文
共 38 条
[21]   Self-Assembly of Ibuprofen and Bovine Serum Albumin-Dextran Conjugates Leading to Effective Loading of the Drug [J].
Li, Juan ;
Yao, Ping .
LANGMUIR, 2009, 25 (11) :6385-6391
[22]   Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect [J].
Maeda, H. ;
Bharate, G. Y. ;
Daruwalla, J. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (03) :409-419
[23]   Preclinical and clinical studies of anticancer agent-incorporating polymer micelles [J].
Matsumura, Yasuhiro ;
Kataoka, Kazunori .
CANCER SCIENCE, 2009, 100 (04) :572-579
[24]   Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity [J].
Minotti, G ;
Menna, P ;
Salvatorelli, E ;
Cairo, G ;
Gianni, L .
PHARMACOLOGICAL REVIEWS, 2004, 56 (02) :185-229
[25]   PEGylated nanoparticles for biological and pharmaceutical applications [J].
Otsuka, H ;
Nagasaki, Y ;
Kataoka, K .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (03) :403-419
[26]   Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) [J].
Passirani, C ;
Barratt, G ;
Devissaguet, JP ;
Labarre, D .
PHARMACEUTICAL RESEARCH, 1998, 15 (07) :1046-1050
[27]   Biopolymer albumin for diagnosis and in drug delivery [J].
Patil, GV .
DRUG DEVELOPMENT RESEARCH, 2003, 58 (03) :219-247
[28]  
Patil RR, 2008, CRIT REV THER DRUG, V25, P1
[29]   Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: Focus on cardio- and testicular toxicity [J].
Pereverzeva, E. ;
Treschalin, I. ;
Bodyagin, D. ;
Maksimenko, O. ;
Langer, K. ;
Dreis, S. ;
Asmussen, B. ;
Kreuter, J. ;
Gelperina, S. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 337 (1-2) :346-356
[30]  
PETERS T, 1978, ALBUMIN STRUCTURE BI, P11